In plain language
In a review of published endovascular aneurysm repair (EVAR) studies, the reported dose-area product was lowest in hybrid rooms and highest with fixed systems. Teams that reported following as low as reasonably achievable (ALARA) tended to report lower doses. Complex repairs sometimes produced concerning doses for patients and staff.
At a glance
- Type of study
- Systematic review or meta-analysis, Systematic review
- Who was studied
- Vascular surgeons, Mixed lab staff, Patients
- Summary based on
- the abstract
What it found
Dose-area product during standard and complex EVAR was lowest in hybrid rooms and highest with fixed systems.
Studies where authors stated adherence to ALARA principles tended to report among the lowest doses.
Several studies, particularly of fenestrated/branched EVAR, reported concerning radiation levels for both patients and staff.
Modern imaging equipment, team engagement in radiation management, and fusion imaging help reduce dose; authors recommend investment in modern imaging technology.
Limits to keep in mind
Literature review of heterogeneous observational studies from MEDLINE and Cochrane only, English full text, with no quantitative pooling reported in the abstract. Dose-area product is mainly a patient dose metric, and staff dose data are summarized only qualitatively.
Related research summaries
- Radiation Safety and Protection - StatPearls (2024, Narrative review)
- AAPM Medical Physics Practice Guideline 12.a - Fluoroscopy Dose Management (2022, Guideline or consensus statement)
- Radiation protection practices in diagnostic and interventional cardiology: Position paper from Portuguese Association of Interventional Cardiology (2025, Guideline or consensus statement)
- Radiation Safety in Chronic Total Occlusion Percutaneous Coronary Intervention (2025, Narrative review)
- Safety of Fluoroscopy - StatPearls (2024, Narrative review)
How this summary was made
ORSIF prepared this summary with AI assistance from the abstract of the paper. A program then checked that the passage supporting each finding appears word for word in that source. A person has not yet reviewed each summary, so read the original before relying on a number. ORSIF summarizes research and does not endorse any product or company. Report a problem with this summary.
Prepared November 5, 2026.